The Ministry of Electronics and Information Technology published an expression of interest in October 2026 inviting Indian industry and research consortia to develop a domestically designed 1.5 Tesla magnetic resonance imaging scanner, according to the notice posted on MeitY’s whats-new page and mirrored in procurement trackers that hospital technology vendors monitor. The document sets performance benchmarks comparable to imported 1.5T workhorse machines—brain, spine and abdominal protocols—while insisting on local value addition, software sovereignty and service networks inside India.
Why 1.5 Tesla still matters
Higher-field 3T scanners dominate academic headlines, but district hospitals and imaging chains buy 1.5T systems for throughput and total cost of ownership. India imports the bulk of installed MRI bases from global OEMs; rupee depreciation and long spare-part lead times raised all-in imaging costs after the pandemic backlog cleared. An indigenous 1.5T platform, if it clears clinical trials and Central Drugs Standard Control Organisation licensing, could sit in the sweet spot for Ayushman Bharat empaneled hospitals and state health missions.
MeitY’s EOI is not a purchase order; it is a market sounding that precedes potential prototype funding, production-linked incentive alignment or joint development with Defence Research and Development Organisation spin-offs already active in superconducting magnets.
What the EOI asks for
Respondents must outline magnet stability, gradient coil performance, radio-frequency subsystem design and image reconstruction software that can be maintained without foreign source-code escrow. Manufacturing plans should show domestic content thresholds, test bays and field service density in tier-two cities where MRI demand grew fastest in 2024–2026 health statistics cited by NITI Aayog reviews.
Timelines in the EOI sketch multi-year phases: concept validation, clinical collaborator tie-ups with All India Institute of Medical Sciences-style centres, then pilot installs. Penalties for missing localization milestones are not financial yet—they are eligibility gates for subsequent tranches.
Industrial policy context
MeitY’s move parallels Production Linked Incentive schemes for medical devices and the National Policy on Electronics’ push to cut import bills in critical hospital gear. Prime Minister Narendra Modi’s speeches at health-tech summits have repeatedly name-checked imaging independence; this EOI gives bureaucratic form to that rhetoric without committing budget lines in the public PDF.
Domestic firms including public-sector units and venture-backed imaging startups have chased MRI components—gradient amps, cryocoolers, RF coils—for a decade with partial success. A full-system integrator role is the harder jump; the EOI explicitly welcomes consortium bids rather than solo applicants.
Hospital buyer perspective
Radiology administrators will ask three questions: image quality parity with GE or Siemens 1.5T workhorses, uptime guarantees, and whether Indian banks will finance installs under state lease models. Until CDSCO registers a device and insurers recognize scans, buyers will not retire imported gantries.
Service is the hidden cost. OEMs win tenders with bundled multiyear contracts; an Indian scanner must show spare magnet parts and trained engineers within hours in cities like Lucknow and Coimbatore, not only in Delhi and Mumbai.
Competition and risk
Global vendors may partner as minority technology suppliers while claiming PLI credit through local assembly—MeitY will need anti-circumvention rules if the policy goal is genuine design ownership. Academics worry about repeating the ultrasound story: assembly localized while core IP stayed abroad.
Clinical validation is non-negotiable. Ethical clearance for trial cohorts, comparison reads by blinded radiologists, and publication in Indian Journal of Radiology and Imaging–style venues will determine whether doctors trust indigenous scans for oncology staging.
What comes next
EOI responses typically close within thirty to forty-five days on MeitY tenders, followed by short-list presentations at Electronics Niketan in New Delhi. Budget alignment with the IndiaAI and health missions may appear in the winter session supplementary demand, though that is speculative until the finance ministry acts.
For Vikram Reddy’s technology desk, the October 2026 verifiable step is procedural: MeitY floated an indigenous 1.5T MRI expression of interest on its whats-new page, inviting consortia to prove India can design, build and service a hospital MRI stack—not just import magnets and wrap plastic panels.